跳至主要内容
临床试验/TCTR20220606005
TCTR20220606005招募中不适用

Effect of beta-hydroxy-beta-methylbutyrate (HMB) enriched oral nutrition supplement on surgical outcomes and physical performance in colorectal cancer patients: a randomized Controlled Trial

Siriraj hospital Mahidol university0 个研究点目标入组 52 人开始时间: 2022年6月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • 1. age more than 18 years old ,Diagnosed of colorectal cancer
  • 2. Nutritional risk score (NRS) more than or equal 3
  • 3. Underwent elective colectomy and/or proctectomy at Colorectal unit, General surgery division, Department of surgery, Siriraj hospital Mahidol university
  • 4. able to communicate and agree to participate in the study

排除标准

  • 1. uninformed his/her diagnosis of colorectal cancer
  • 2. non colorectal resection procedure eg. proximal colostomy, colonic stenting
  • 3. Emergency colorectal cancer surgery eg. perforate, obstruction
  • 4. pregnancy
  • 5. unable to communicate or walk eg. stroke, bed ridden, cognitive impairment etc.
  • 6. limb amputation
  • 7. GFR <30
  • 8. Dysphagia
  • 9. cow milk allergy

研究者

发起方
Siriraj hospital Mahidol university

相似试验